Syros Pharmaceuticals, Inc. (SYRS) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 4 recommend buying, 5 recommend holding, and 0 recommend selling.
The analyst consensus price target for SYRS is $16.67, representing a +4,762,757.1% upside from the current price of $0.00035. Price targets range from a low of $5.00 to a high of $30.00.
